Immunosuppressive drugs : developments in anti-rejection therapy
著者
書誌事項
Immunosuppressive drugs : developments in anti-rejection therapy
Edward Arnold, 1994
大学図書館所蔵 件 / 全2件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes index (p. 231-235)
内容説明・目次
内容説明
Provides a review of recent developments in the field of drugs that suppress the body's immune system in response to a transplanted organ, thus preventing rejection.
目次
- Conventional immunosuppressive drugs, I.R.Marino and H.R.Doyle
- molecular actions of cyclosporin A, FK506 and rapamycin, D.A.Fruman et al
- pharmacokinetics and monitoring of cyclosporin A, D.W.Holt and A.Johnston
- cellular immunobiology of cyclosporin, A.D.Hess
- influence of cyclosporin A on graft rejection, P.A.Keown
- pharmacokinetics and monitoring of FK506, R.Venkataramanan and V.Warty
- influence of FK506 on lymphocyte responses in vitro and in vivo, A.W.Thomson et al
- influence of FK506 on experimental transplantation, T.Ochiai
- influence of FK506 in clinical transplantation, J.J.Fung et al
- immunosuppressive role of rapamycin in allograft rejection, M.J.Boyle and B.D.Kahan
- mycophenolate mofetil (RS-61443): mode of action and effects on graft rejection, A.C.Allison and E.M.Eugui
- mizoribine (Bredinin): mode of action and effects on graft rejection, H.Amemiya and H.Itoh
- brequinar sodium: mode of action and effects on graft rejection, S.Suzuki
- leflunomide: a promising immunosuppressant in transplantation, F.Xiao et al
- SK&F 105685, J.W.Kupiec-Weglinski et al
- promotion of cell chimerism by immunosuppressive drugs, A.W.Thomson et al.
「Nielsen BookData」 より